Clinical Trial Update: Trial Comparing Trabectedin to the Best Supportive Care in Patients With Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing trabectedin to best supportive care in soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: COMPLETED